Briefing: Opinion: Medical misinformation wins when patients can’t see their doctors
Strategic angle: Desperate patients, unable to get timely doctors’ appointments, seek help wherever they can find it.
Strategic angle: Desperate patients, unable to get timely doctors’ appointments, seek help wherever they can find it.
Strategic angle: The daily pill called Foundayo got a fast track through the Food and Drug Administration.
The rapper "started feeling very ill" mid-way through the show in New York, her representative told US media.
Strategic angle: Who is the sport's most dominant pitcher right now? We rank the elite, with the help of MLB scouts and execs.
Strategic angle: Tuesday's ruling reinstates the immigration status of those who came via CBP One and whose status was terminated.
Strategic angle: A delayed FDA decision for Orca Bio, new questions about pharma-telehealth tie-ups, and more
Strategic angle: When Zeus, a medical student living in a hilltop city in central Nigeria, returns to his studio apartment from a long day at the hospital, he turns on his ring light, straps his iPhone to his forehead, and starts recordi
Strategic angle: A new study explores whether incorporating psychotherapy with ketamine treatment enhances its effectiveness.
Strategic angle: “Rigorously derived evidence for the medical efficacy of marijuana is thin,” writes Kevin Sabet.
Strategic angle: It's peak fire season in the Thai city, which now ranks as one of the world's most polluted.
Strategic angle: An article published in CABI Agriculture and Bioscience advocates for a diverse approach combining indigenous knowledge and modern technologies to combat plant diseases in Africa.
Strategic angle: A breakthrough in the fight against superbugs and antimicrobial resistance.
Strategic angle: Health Secretary Kennedy's upcoming decision on peptides could reshape the wellness industry.
Strategic angle: The Trump administration reverts the name of the federal health IT office to the Office of the National Coordinator.
Strategic angle: An analysis of the current market sentiment surrounding Omega Healthcare Investors, Inc.
Strategic angle: OpenEvidence partners with a significant health system to enhance health record sharing.
Strategic angle: Drugmakers are postponing the release of new medicines in Europe due to shifting pricing policies and pressures from the U.S.
Strategic angle: Lead exposure and heart disease, promoting psychedelics on YouTube, and other health news from Morning Rounds
Strategic angle: Here’s Why Fresenius Medical Care AG (FMS) Remains Attractive
Strategic angle: “The CDC stands at an inflection point,” write Charles J. Lockwood, Robert C. Gallo, and Sten H. Vermund.